5 Stocks Under $20 to Buy Today According to Nishkama Capital

4. Clarivate Plc (NYSE:CLVT)

Nishkama Capital’s Stake Value: $2.3 million

Percentage of Nishkama Capital’s 13F Portfolio: 0.57%

Number of Hedge Fund Investors: 42

Stock Price as of May 16, 2022: $14.35

Clarivate Plc (NYSE:CLVT) is a British information services and analytics company which offers services in the fields of drug discovery, scientific research, evaluating new products, and regulatory approval. The company is based in London.

Clarivate Plc (NYSE:CLVT) earned $663 million in revenue and $0.21 in non-GAAP EPS for its fiscal Q1, beating analyst estimates for EPS only. Stifel lowered its price target to $19 from $24 in March 2022, stating that its share price drops are not tied to fundamentals.

Nishkama Capital held a $2.3 million stake in Clarivate Plc (NYSE:CLVT) as the fourth quarter of last year came to an end. It came in the form of 100,000 shares and represented 0.57% of the firm’s portfolio. Insider Monkey’s 924 hedge fund survey for the same time period revealed that 42 had also invested in the company.

Clarivate Plc (NYSE:CLVT)’s largest investor is Leonard Green’s Leonard Green & Partners which owns a $2.7 billion stake that comes through 116 million shares.